Paper4402298
Recent experimental, clinical, and therapeutic research on the problems of intraocular pressure and glaucoma.
Bietti G. Am J Ophthalmol, 1972. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Recent experimental, clinical, and therapeutic research on the problems of intraocular pressure and glaucoma. Papers, record 4402298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4402298
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent experimental, clinical, and therapeutic research on the problems of intraocular pressure and glaucoma.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aqueous Humor | Major topic |
| Glaucoma | Major topic |
| Intraocular Pressure | Major topic |
| Adrenergic beta-Antagonists | |
| Animals | |
| Anterior Chamber | |
| Ascorbic Acid | |
| Calcium Chloride | |
| Carbonic Anhydrase Inhibitors | |
| Glucose | |
| Glycosaminoglycans | |
| Gonioscopy | |
| Hypertonic Solutions | |
| Hypotonic Solutions | |
| Injections, Intravenous | |
| Isotonic Solutions | |
| Osmolar Concentration | |
| Propylene Glycols | |
| Rabbits | |
| Sodium Chloride | |
| Tonometry, Ocular |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38654174 | Iris neovascularization and neurotrophic keratopathy following ultrasound cycloplasty in refractory glaucoma: case series. | BMC Ophthalmol | 2024 | https://conductscience.org/library/papers/38654174 | PubMed |
| 6714071 | Some aspects of waterloadings in rabbits. | Doc Ophthalmol | 1984 | https://conductscience.org/library/papers/6714071 | PubMed |
| 356658 | Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1978 | https://conductscience.org/library/papers/356658 | PubMed |
| 341739 | Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1977 | https://conductscience.org/library/papers/341739 | PubMed |
| 335912 | Intraocular pressure reduction during treatment with pilocarpine and systemic propranolol. A comparative double-masked study. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1977 | https://conductscience.org/library/papers/335912 | PubMed |
| 240378 | Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker. | Br J Ophthalmol | 1975 | https://conductscience.org/library/papers/240378 | PubMed |
| 38956 | The treatment of glaucoma: role of beta-blocking agents. | Drugs | 1979 | https://conductscience.org/library/papers/38956 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4402298
GET https://conductscience.org/api/papers/v1/4402298/authors